Court OKs Pharma Investors' $12.7M Deal Over Drug Trial
A California federal judge granted preliminary approval of the $12.7 million settlement between Odonate Therapeutics Inc. and investors on Wednesday, ending a class action that accused the pharmaceutical company of misleading...To view the full article, register now.
Already a subscriber? Click here to view full article